COVID-19 in dialysis patients

Completed

• Conditions: Coronavirus as the cause of diseases classified elsewhere,

• Registration Number: CTRI/2020/06/026152
• Lead Sponsor: Seth GS Medical College and KEM Hospital

Brief Summary

The worldwide spread of the COVID-19 pandemic due to the novel SARS-CoV-2 virus, poses a significant challenge to the medical fraternity today. This pandemic that has enveloped the globe, started as a local outbreak in the Chinese province of Wuhan in December 2019. Patients of Chronic kidney disease (CKD) are deemed as a population susceptible to COVID-19 illness. Especially patients of End-Stage Renal Disease (ESRD) on Maintenance Haemodialysis (MHD) are an especially vulnerable group since they are inherently involved in getting exposed to high-risk medical environments of dialysis units for the purpose of scheduled dialysis treatments. The behavior of COVID-19 illness in dialysis patients has not been studied systematically, due to the present circumstances of unprecedented crisis. This crucial acquisition of information will lead to better understanding and management of these patients during this pandemic crisis. Mumbai, one of the largest epicenter of the disease in our country, has a large dialysis population currently facing this challenge. Our study aims to scientifically look at the presentation, clinical features, laboratory parameters and outcomes of such patients on haemodialysis in Mumbai who are admitted to KEMH with COVID-19 positive status. The analysis of this data will be of the utmost use to patient care.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-01-12
• Study Start: 2020-06-26

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Patients with ESRD on Maintenance Haemo-dialysis admitted to KEM Hospital with the diagnosis of COVID-19 by CDC criteria 2.
• All age groups and both genders are to be included.

Exclusion Criteria

Patients with incomplete medical records.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcome of haemodialysis patients with covid 19 infection	3 months

Secondary Outcome Measures

Name	Time	Method
1.To find clinical features, laboratory parameters and course of disease	2.To find any predictors or severity of disease

Trial Locations

Locations (1)

Seth G.S. Medical College and KEM Hospital; 🇮🇳 Mumbai, MAHARASHTRA, India

Seth G.S. Medical College and KEM Hospital

🇮🇳Mumbai, MAHARASHTRA, India

Dr Tukaram Jamale

Principal investigator

9167460362

tukaramjamale@yahoo.co.in